These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 8179864)

  • 1. Isolation and characterization of trypsin-like and chymotrypsin-like proteinases from human cholesteatoma.
    Hochstrasser K; Albrecht GJ; Gebhard W; Rasp G; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1994; 251(1):30-5. PubMed ID: 8179864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification and identification of two serine class proteinases from dog mast biochemically and immunologically similar to human proteinases tryptase and chymase.
    Schechter NM; Slavin D; Fetter RD; Lazarus GS; Fräki JE
    Arch Biochem Biophys; 1988 Apr; 262(1):232-44. PubMed ID: 3128177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut.
    Miller HR; Pemberton AD
    Immunology; 2002 Apr; 105(4):375-90. PubMed ID: 11985658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of human mast cell tryptase and chymase with low-molecular-mass serine proteinase inhibitors from the human respiratory tract.
    Hochstrasser K; Gebhard W; Albrecht G; Rasp G; Kastenbauer E
    Eur Arch Otorhinolaryngol; 1993; 249(8):455-8. PubMed ID: 8442939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a cathepsin G-like proteinase in the MCTC type of human mast cell.
    Schechter NM; Irani AM; Sprows JL; Abernethy J; Wintroub B; Schwartz LB
    J Immunol; 1990 Oct; 145(8):2652-61. PubMed ID: 2212656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chymotrypsin- and trypsin-type serine proteases in rat mast cells: properties and functions.
    Kido H; Fukusen N; Katunuma N
    Arch Biochem Biophys; 1985 Jun; 239(2):436-43. PubMed ID: 3890754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in mast cell proteinases and protease inhibitors in the progress of cutaneous herpes zoster infection.
    Kaminska R; Harvima IT; Naukkarinen A; Nilsson G; Horsmanheimo M
    J Pathol; 1996 Dec; 180(4):434-40. PubMed ID: 9014866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tryptase in rat mast cells: properties and inhibition by various inhibitors in comparison with chymase.
    Muramatu M; Itoh T; Takei M; Endo K
    Biol Chem Hoppe Seyler; 1988 Jul; 369(7):617-25. PubMed ID: 3066368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of enzymatic activity of human mast cell tryptase and chymase by protease inhibitors.
    He SH; Chen P; Chen HQ
    Acta Pharmacol Sin; 2003 Sep; 24(9):923-9. PubMed ID: 12956943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Soybean Bowman-Birk protease inhibitor is a highly effective inhibitor of human mast cell chymase.
    Ware JH; Wan XS; Rubin H; Schechter NM; Kennedy AR
    Arch Biochem Biophys; 1997 Aug; 344(1):133-8. PubMed ID: 9244390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Release of soluble tryptase but only minor amounts of chymase activity from cutaneous mast cells.
    Kivinen PK; Kaminska R; Naukkarinen A; Harvima RJ; Horsmanheimo M; Harvima IT
    Exp Dermatol; 2001 Aug; 10(4):246-55. PubMed ID: 11493313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mast cell tryptase and chymase in chronic leg ulcers: chymase is potentially destructive to epithelium and is controlled by proteinase inhibitors.
    Huttunen M; Harvima IT
    Br J Dermatol; 2005 Jun; 152(6):1149-60. PubMed ID: 15948975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reaction of mast cell proteases tryptase and chymase with protease activated receptors (PARs) on keratinocytes and fibroblasts.
    Schechter NM; Brass LF; Lavker RM; Jensen PJ
    J Cell Physiol; 1998 Aug; 176(2):365-73. PubMed ID: 9648924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Guinea pig lung tryptase. Localisation to mast cells and characterisation of the partially purified enzyme.
    McEuen AR; He S; Brander ML; Walls AF
    Biochem Pharmacol; 1996 Jul; 52(2):331-40. PubMed ID: 8694858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibitors of chymase as mast cell-stabilizing agents: contribution of chymase in the activation of human mast cells.
    He S; Gaça MD; McEuen AR; Walls AF
    J Pharmacol Exp Ther; 1999 Nov; 291(2):517-23. PubMed ID: 10525066
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of tryptase release from human tonsil mast cells by protease inhibitors.
    He S; Xie H
    Pharmacol Rep; 2005; 57(4):523-30. PubMed ID: 16129920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mast cell tryptases and airway remodeling.
    Sommerhoff CP
    Am J Respir Crit Care Med; 2001 Nov; 164(10 Pt 2):S52-8. PubMed ID: 11734467
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterisation of tryptase and a granzyme H-like chymase isolated from equine mastocytoma tissue.
    Pemberton AD; McEuen AR; Scudamore CL
    Vet Immunol Immunopathol; 2001 Dec; 83(3-4):253-67. PubMed ID: 11730933
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of mast cell proteases from murine skin.
    Algermissen B; Laubscher JC; Bauer F; Henz BM
    Exp Dermatol; 1999 Oct; 8(5):413-8. PubMed ID: 10536969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pericellular substrates of human mast cell tryptase: 72,000 dalton gelatinase and fibronectin.
    Lohi J; Harvima I; Keski-Oja J
    J Cell Biochem; 1992 Dec; 50(4):337-49. PubMed ID: 1469068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.